GW-1100
- CAS No.
- 306974-70-9
- Chemical Name:
- GW-1100
- Synonyms
- GW-1100;GW1100;GW1100;GW-1100 (SB-376752);GPR40 Antagonist, GW1100;GPR40 Antagonist, GW1100 - CAS 306974-70-9 - Calbiochem;1-(4-Ethoxycarbonylphenyl)-2-(4-fluorobenzylthio)-5-(2-ethoxy-5-pyrimidinylmethyl)-4-pyrimidinone;ethyl 4-(5-((2-ethoxypyrimidin-5-yl)methyl)-2-((4-fluorobenzyl)thio)-4-oxopyrimidin-1(4H)-yl)benzoate;Benzoic acid, 4-[5-[(2-ethoxy-5-pyrimidinyl)methyl]-2-[[(4-fluorophenyl)methyl]thio]-4-oxo-1(4H)-pyrimidinyl]-, ethyl ester
- CBNumber:
- CB01872299
- Molecular Formula:
- C27H25FN4O4S
- Molecular Weight:
- 520.58
- MDL Number:
- MFCD09953714
- MOL File:
- 306974-70-9.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Melting point | 208-210℃ |
|---|---|
| Boiling point | 690.2±65.0 °C(Predicted) |
| Density | 1.29±0.1 g/cm3(Predicted) |
| storage temp. | +2C to +8C |
| solubility | Soluble in DMSO (up to 2 mg/ml) or in DMF (up to 5 mg/ml). |
| form | White powder |
| pka | 1.20±0.22(Predicted) |
| color | White |
| Stability | Stable for 1 year from date of purchase as supplied. Solutions in DMSO or DMF may be stored at -20° for up to 3 months. Dilutions into aqueous media are not stable and should be used within one working day. |
| InChIKey | PTPNCCWOTBBVJR-UHFFFAOYSA-N |
| SMILES | FC(C=C1)=CC=C1CSC(N(C2=CC=C(C(OCC)=O)C=C2)C=C3CC4=CN=C(N=C4)OCC)=NC3=O |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
GW-1100 price More Price(32)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | 371830 | GPR40 Antagonist, GW1100 - CAS 306974-70-9 - Calbiochem The GPR40 Antagonist, GW1100, also referenced under CAS 306974-70-9, controls the biological activity of GPR40. This small molecule/inhibitor is primarily used for Biochemicals applications. |
306974-70-9 | 10mg | $340 | 2026-04-30 | Buy |
| Cayman Chemical | 10008908 | GW 1100 ≥95% | 306974-70-9 | 5mg | $81 | 2026-04-30 | Buy |
| Cayman Chemical | 10008908 | GW 1100 ≥95% | 306974-70-9 | 10mg | $152 | 2026-04-30 | Buy |
| Cayman Chemical | 10008908 | GW 1100 ≥95% | 306974-70-9 | 25mg | $239 | 2026-04-30 | Buy |
| Cayman Chemical | 10008908 | GW 1100 ≥95% | 306974-70-9 | 50mg | $436 | 2026-04-30 | Buy |
GW-1100 Chemical Properties, Uses, Production
Description
GW1100 (306974-70-9) is a selective antagonist of GPR40. GW1100 inhibits GRP40-mediated Ca2+increases stimulated by GW9508 (Cat.# 10-1108) or linoleic acid (pIC50= 5.99 for either agonist).1The effects of GPR40 activation on insulin secretion in cells are also blocked by the addition of GW1100. GW1100 does not influence calcium mobilization mediated by GPR120.
Uses
GW 1100 is a selective G protein-coupled receptor GPR40 antagonist. GW 1100 has been shown to reverse the effects GPR40 agonists which induce glucose-stimulated insulin secretion.
Biological Activity
GW-1100 is a selective GPR40 antagonist with pIC50 of 6.9.
in vitro
GW-1100 (GW1100) dose dependently inhibits GPR40-mediated Ca 2+ elevations stimulated by GW9508 and linoleic acid (pIC 50 values of 5.99±0.03 and 5.99±0.06, respectively). GW-1100 at a concentration of 1 μM produces a significant rightward shift in the concentration-response curve to GW9508 (pEC 50 =7.17±0.08 in the absence and pEC 50 =6.79±0.09 in the presence of 1 μM GW-1100; P<0.05; n=3). At concentrations of GW-1100 of 3 μM and higher a significant decrease in the maximal response is observed with a continuing rightward shift in the pEC 50 response. GW-1100 (GW1100) reduces FFAR1 ligand-induced intracellular calcium in CHO-K1/bFFAR1 cells and neutrophils. CHO-K1/bFFAR1 cells are incubated for 15 min with 10 μM GW1100 or vehicle (0.1% DMSO) and then stimulated with vehicle, oleic acid, linoleic acid or GW9508. GW-1100 significantly reduces the increase in intracellular calcium induced by 300 μM oleic acid (AUC (60-150 s) , p<0.05), 100 μM linoleic acid (AUC (60-150 s) , p<0.05) and 10 μM GW9508 (AUC (60-150 s) , p<0.05).
in vivo
The intracerebroventricular injection of DHA (50 μg) and GW9508 (1.0 μg), a GPR40-selective agonist, significantly reduces mechanical allodynia and thermal hyperalgesia at day 7, but not at day 1, after CFA injection. These effects are inhibited by intracerebroventricular pretreatment with GW-1100 (10 μg), a GPR40 antagonist.
References
[1] CELIA P BRISCOE. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules[J]. British Journal of Pharmacology, 2009, 148 5: 619-628. DOI:10.1038/sj.bjp.0706770
[2] TAKAHIRO NAGATAKE PHD , PHD Tetsuya H M, PHD , et al. The 17,18-epoxyeicosatetraenoic acid–G protein–coupled receptor 40 axis ameliorates contact hypersensitivity by inhibiting neutrophil mobility in mice and cynomolgus macaques[J]. Journal of Allergy and Clinical Immunology, 2018, 142 2: Pages 470-484.e12. DOI:10.1016/j.jaci.2017.09.053
GW-1100 Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| J & K SCIENTIFIC LTD. | 18210857532 18210857532 | jkinfo@jkchemical.com | China | 96815 | 76 |
| BOC Sciences | 1-631-485-4226; 16314854226 | info@bocsci.com | United States | 9920 | 65 |
| Dalian Meilun Biotech Co., Ltd. | 0411-62910999 13889544652 | sales@meilune.com | China | 4765 | 58 |
| Haoyuan Chemexpress Co., Ltd. | 021-58950125 | info@chemexpress.com | China | 7545 | 61 |
| ShangHai Caerulum Pharma Discovery Co., Ltd. | 18149758185 18149758185 | sales-cpd@caerulumpharma.com | China | 3493 | 58 |
| LETOPHARM LIMITED | +86-21-5821 5861 | sales@letopharm.com | China | 2374 | 58 |
| SPIRO PHARMA | eric_feng1954@126.com | China | 9239 | 55 | |
| Guangzhou QiYun Biotechnology Co., Ltd. | 020-61288194 61288195 | 505721671@qq.com | China | 3853 | 58 |
| Chengdu Huachun Technology Co., Ltd | 400-1166-196 15982826727 | cdhxsj@163.com | China | 14571 | 60 |
| Amadis Chemical Company Limited | 571-89925085 | sales@amadischem.com | China | 131885 | 58 |
